Pharmafile Logo
Pharmafocus logo
Advanced Search

patent

Showing 15 posts of 30 posts found.

gavel

Judge reverses verdict in MSD/Gilead hepatitis C dispute

June 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gilead, MSD, Merck, dispute, patent, reversal, sovaldi

A US district judge has reversed a previous court decision which favoured MSD, called Merck in the US, over Gilead …

News
sovaldi-web

Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access

May 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi

Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …

News
gavel

Baxalta sues Chugai for haemophilia drug patent breach

May 11, 2016
Research and Development Baxalta, Chugai, breach, court, haemophilia, infringe, infringement, patent, sue, suing

Baxalta has taken Chugai Pharmaceuticals to the Tokyo district court, claiming that the Japanese company has infringed upon its patent …

News
google

Google files for US patent to electronic eye lens

May 3, 2016
Manufacturing and Production, Research and Development Alphabet, google, lens, patent, research

Alphabet Inc (Nasdaq: GOOG) has filed a patent application for a device that can be implanted in the eye to …

News
v2_crestor_10_mg

Allergan launches Crestor generic in the US

May 3, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales

Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …

News
gavel

Roche sues Intas Pharma over patent dispute in India

April 18, 2016
Medical Communications, Sales and Marketing India, Roche, anaemia, chronic kidney, intas, intas pharmaceuticals, patent

Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …

News
novartis_window

Research shows Novartis’s Entresto reduces cardiovascular death and heart failure

April 4, 2016
Research and Development, Sales and Marketing Entresto, Novartis, Regeneron, Sanofi, cardiovascular, clinical trial, patent

Novartis has announced results from the PARADIGM-HF clinical trial that show that Entresto (sacubitril/valsartan) consistently demonstrated benefit among heart failure …

News
magic_bullets_pills

Almost half of US physicians will prescribe more biosimilars, according to survey

March 4, 2016
Medical Communications Obama, US, biosimilar, patent, prescribing

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …

News
clinical trial

The biggest side-effect of making medicine

September 16, 2015
Research and Development evergreening, intellectual property, patent

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …

Feature
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

News

January deadline for Pfizer restructure

July 30, 2013
Research and Development, Sales and Marketing Pfizer, patent, restructure

Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …

News
merck_incweb

Merck’s Singulair faces generic rivals

August 7, 2012
Sales and Marketing Merck, Singulair, generic erosion, patent

Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …

News

NHS spending on drugs fell in 2011

April 4, 2012
Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend

The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …

News

Watson submits Crestor copycat

October 28, 2010
Sales and Marketing AstraZeneca, Crestor, Watson, generic, patent

 Watson Pharmaceuticals is seeking to launch a generic version of  AstraZeneca cholesterol blockbuster Crestor, exploiting weaknesses in its patent. The …

News

Pharma welcomes UK pre-budget report

December 14, 2009
Research and Development patent, tax

The pharma and healthcare sectors have been unpicking the implications of last week’s Pre-Budget Report (PBR) by chancellor Alastair Darling.The …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026